NEW PHARMACEUTICAL COMBINATIONS FOR THE TREATMENT OF RESPIRATORY AND GASTROINTESTINAL DISORDERS

摘要

The present invention relates to novel pharmaceutical compositions compri sing at least one EGFR kinase inhibitor and at least one additional active c ompound selected from beta-2 mimetics, steroids, PDE-IV inhibitors, p38 MAP kinase inhibitors, NK1 antagonists, anticholinergics and endothelin antagoni sts, processes for preparing the compositions and the use thereof as medicam ent in the treatment of respiratory or gastrointestinal complaints, as well as inflammatory diseases of the joints, the skin or the eyes.